203 related articles for article (PubMed ID: 20394437)
1. Dendrimer internalization and intracellular trafficking in living cells.
Albertazzi L; Serresi M; Albanese A; Beltram F
Mol Pharm; 2010 Jun; 7(3):680-8. PubMed ID: 20394437
[TBL] [Abstract][Full Text] [Related]
2. The effect of surface functionality on cellular trafficking of dendrimers.
Perumal OP; Inapagolla R; Kannan S; Kannan RM
Biomaterials; 2008; 29(24-25):3469-76. PubMed ID: 18501424
[TBL] [Abstract][Full Text] [Related]
3. Surface modification of PAMAM dendrimers modulates the mechanism of cellular internalization.
Saovapakhiran A; D'Emanuele A; Attwood D; Penny J
Bioconjug Chem; 2009 Apr; 20(4):693-701. PubMed ID: 19271737
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic insight into cell growth, internalization, and cytotoxicity of PAMAM dendrimers.
Parimi S; Barnes TJ; Callen DF; Prestidge CA
Biomacromolecules; 2010 Feb; 11(2):382-9. PubMed ID: 20038138
[TBL] [Abstract][Full Text] [Related]
5. Internalization and Subcellular Trafficking of Poly-l-lysine Dendrimers Are Impacted by the Site of Fluorophore Conjugation.
Avaritt BR; Swaan PW
Mol Pharm; 2015 Jun; 12(6):1961-9. PubMed ID: 25950742
[TBL] [Abstract][Full Text] [Related]
6. Endocytosis inhibitors prevent poly(amidoamine) dendrimer internalization and permeability across Caco-2 cells.
Kitchens KM; Kolhatkar RB; Swaan PW; Ghandehari H
Mol Pharm; 2008; 5(2):364-9. PubMed ID: 18173246
[TBL] [Abstract][Full Text] [Related]
7. Transfection efficiencies of PAMAM dendrimers correlate inversely with their hydrophobicity.
Shakhbazau A; Isayenka I; Kartel N; Goncharova N; Seviaryn I; Kosmacheva S; Potapnev M; Shcharbin D; Bryszewska M
Int J Pharm; 2010 Jan; 383(1-2):228-35. PubMed ID: 19770028
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of PAMAM Dendrimers Internalization in Hippocampal Neurons.
Vidal F; Vásquez P; Díaz C; Nova D; Alderete J; Guzmán L
Mol Pharm; 2016 Oct; 13(10):3395-3403. PubMed ID: 27556289
[TBL] [Abstract][Full Text] [Related]
9. Alkyl sulfonyl derivatized PAMAM-G2 dendrimers as nonviral gene delivery vectors with improved transfection efficiencies.
Morales-Sanfrutos J; Megia-Fernandez A; Hernandez-Mateo F; Giron-Gonzalez MD; Salto-Gonzalez R; Santoyo-Gonzalez F
Org Biomol Chem; 2011 Feb; 9(3):851-64. PubMed ID: 21120228
[TBL] [Abstract][Full Text] [Related]
10. Biotinylated poly(amido)amine (PAMAM) dendrimers as carriers for drug delivery to ovarian cancer cells in vitro.
Yellepeddi VK; Kumar A; Palakurthi S
Anticancer Res; 2009 Aug; 29(8):2933-43. PubMed ID: 19661298
[TBL] [Abstract][Full Text] [Related]
11. On the ability of PAMAM dendrimers and dendrimer/DNA aggregates to penetrate POPC model biomembranes.
Ainalem ML; Campbell RA; Khalid S; Gillams RJ; Rennie AR; Nylander T
J Phys Chem B; 2010 Jun; 114(21):7229-44. PubMed ID: 20455596
[TBL] [Abstract][Full Text] [Related]
12. Conjugation of polyamidoamine dendrimers on biodegradable microparticles for nonviral gene delivery.
Zhang XQ; Intra J; Salem AK
Bioconjug Chem; 2007; 18(6):2068-76. PubMed ID: 17848077
[TBL] [Abstract][Full Text] [Related]
13. Intrinsically fluorescent PAMAM dendrimer as gene carrier and nanoprobe for nucleic acids delivery: bioimaging and transfection study.
Tsai YJ; Hu CC; Chu CC; Imae T
Biomacromolecules; 2011 Dec; 12(12):4283-90. PubMed ID: 22029823
[TBL] [Abstract][Full Text] [Related]
14. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.
Patri AK; Kukowska-Latallo JF; Baker JR
Adv Drug Deliv Rev; 2005 Dec; 57(15):2203-14. PubMed ID: 16290254
[TBL] [Abstract][Full Text] [Related]
15. Receptor-mediated gene delivery using PAMAM dendrimers conjugated with peptides recognized by mesenchymal stem cells.
Santos JL; Pandita D; Rodrigues J; Pêgo AP; Granja PL; Balian G; Tomás H
Mol Pharm; 2010 Jun; 7(3):763-74. PubMed ID: 20230026
[TBL] [Abstract][Full Text] [Related]
16. Transport of dendrimer nanocarriers through epithelial cells via the transcellular route.
Jevprasesphant R; Penny J; Attwood D; D'Emanuele A
J Control Release; 2004 Jun; 97(2):259-67. PubMed ID: 15196753
[TBL] [Abstract][Full Text] [Related]
17. A surface-modified dendrimer set for potential application as drug delivery vehicles: synthesis, in vitro toxicity, and intracellular localization.
Fuchs S; Kapp T; Otto H; Schöneberg T; Franke P; Gust R; Schlüter AD
Chemistry; 2004 Mar; 10(5):1167-92. PubMed ID: 15007808
[TBL] [Abstract][Full Text] [Related]
18. In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM-FITC labeled dendrimer.
Denora N; Laquintana V; Lopalco A; Iacobazzi RM; Lopedota A; Cutrignelli A; Iacobellis G; Annese C; Cascione M; Leporatti S; Franco M
J Control Release; 2013 Dec; 172(3):1111-25. PubMed ID: 24096015
[TBL] [Abstract][Full Text] [Related]
19. Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape.
Foerg C; Ziegler U; Fernandez-Carneado J; Giralt E; Rennert R; Beck-Sickinger AG; Merkle HP
Biochemistry; 2005 Jan; 44(1):72-81. PubMed ID: 15628847
[TBL] [Abstract][Full Text] [Related]
20. The effect of PAMAM G6 dendrimers on the structure of lipid vesicles.
Akesson A; Bendtsen KM; Beherens MA; Pedersen JS; Alfredsson V; Cárdenas Gómez M
Phys Chem Chem Phys; 2010 Oct; 12(38):12267-72. PubMed ID: 20714580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
